Does CABOZANTINIB S-MALATE Cause Neuropathy peripheral? 369 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 369 reports of Neuropathy peripheral have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.9% of all adverse event reports for CABOZANTINIB S-MALATE.
369
Reports of Neuropathy peripheral with CABOZANTINIB S-MALATE
0.9%
of all CABOZANTINIB S-MALATE reports
5
Deaths
41
Hospitalizations
How Dangerous Is Neuropathy peripheral From CABOZANTINIB S-MALATE?
Of the 369 reports, 5 (1.4%) resulted in death, 41 (11.1%) required hospitalization, and 4 (1.1%) were considered life-threatening.
Is Neuropathy peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 369 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Neuropathy peripheral?
LENALIDOMIDE (10,215)
BORTEZOMIB (4,067)
OXALIPLATIN (3,662)
DEXAMETHASONE (3,543)
PACLITAXEL (3,508)
LEVOFLOXACIN (2,619)
CIPROFLOXACIN (2,607)
FLUOROURACIL (2,605)
CYCLOPHOSPHAMIDE (2,565)
POMALIDOMIDE (2,382)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Neuropathy peripheral Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE